Latest News and Press Releases
Want to stay updated on the latest news?
-
Niveau record des produits des activités ordinaires, du BAIIA ajusté1 et du BAIIA ajusté par action1 depuis la créationNiveau record des flux de trésorerie liés aux activités d’exploitation depuis la...
-
Delivered record-high revenues, Adjusted EBITDA1, Adjusted EBITDA per share1 since inceptionGenerated record high cash flow from operations since inceptionProvides 2026 revenues guidance of $490...
-
Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate (cORR) of 52% in serous endometrial cancer (EC) Late-breaking oral presentation...
-
CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
-
SAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced...
-
CANTON, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the largest integrated commerce specialty retailer of Big + Tall men’s clothing and footwear, today...
-
GRAPEVINE, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”), a leading portfolio of lifestyle brands (Solo Stove, Chubbies, ISLE and Oru)...
-
Fourth Quarter Revenue was $662.5 million, a 27.4% increase over the prior year periodFourth Quarter Net income was $178.8 million compared to $29.2 million for the prior year periodAdjusted EBITDA...
-
Breakthrough Therapy Designation granted to nomlabofusp for the treatment of adults and children with FA based on FDA’s review of available clinical data from open label studyContinued alignment with...
-
Sylogist Announces Fourth Quarter and Full Year 2025 Results